Replies to post #298662 on Anavex Life Sciences Corp (AVXL)

[NWDR]

The revenue I estimated is yearly.

Rett patient total; = 30K
40% treated; = 12K
$24000 yearly revenue; = $288M

I'm being very conservative. The treatment cost may be much higher.
Alexion's drug Soliris is listed at $500K per year. This is probably negotiated to be much lower but still points to the conservative nature of the estimates.

Thanks for checking.

NWDR

go AVXL... actually wait another week till I'm fully loaded...